MCC Pura Series:

Advanced Performance meets Nordic Sustainability

Setting a new standard for cellulose products in pharmaceuticals

Top features

1

Uniform particle size for enhanced flowability

Efficient production and less downtime.

2

High compressibility

Enhanced tablet strength.

3

High density

Smaller tablets. Larger batch size.

4

Improved disintegration

Optimal release of active ingredients.

5

Low dust formation

Cleaner, safer production.

One
product.
Unparalleled
properties.

Technical specifications

Product specifications

NBG MCC Pura Series: DC-95 (pre-commercial)

95 μm
Average particle size (d50)
0,59 g/cm3
Bulk density
0,72 g/cm3
Tapped density
16,6
Carr Index (Flowability)

Tableting specifications

NBG MCC Pura Series: DC-95 (pre-commercial)

3500-4500N
Pressing force
100-120N
High strength tablets
2,0%
Low tablet weight deviation

Quality.
Purity.
Safety.
Sustainability.

We follow GMP protocol and Pharmacopeia standards for MCC.

EU ESG reporting requirements compliant.

FSC certified from traceable and sustainably managed forests. ​

Energy-efficient and environmentally friendly process, validated through third-party LCA.

Relentless commitment to lower carbon footprint across all operations.

Supply chain security with production in Finland.​

Talk to our experts

Let’s work together to provide you with the most suitable MCC solution for your needs.

Contact